Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  AFT Pharmaceuticals Limited    AFT   NZAFTE0001S4

AFT PHARMACEUTICALS LIMITED

(AFT)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

AFT Pharmaceuticals : ASM resultsOpens in a new Window

09/08/2020 | 12:30am EST

8 September 2020

Results of 2020 Annual Shareholder Meeting

At AFT Pharmaceuticals Limited's (NZX: AFT / ASX: AFP) annual shareholder meeting held virtually today, shareholders were asked to vote on two resolutions, both of which were supported by the Board.

As required by NZX Listing Rule 6.1, all voting was conducted by a poll.

The resolutions passed by shareholders were:

1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year.

2.

That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

Detail of the total number of votes cast in person or by a proxy holder are:

Resolution

For

Against

Abstain

1.

That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year.

87,540,520 99.99%

11,972 0.01%

2,000

2.

That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

87,552,227 100.00%

1,145 0.00%

120

Authority for this announcement

Name of person authorised to make this announcement

Malcolm Tubby, Chief Financial Officer

Contact person for this announcement

Malcolm Tubby

Contact phone number

+64 9 488 0232

Contact email address

Investor.relations@aftpharm.com

Date of release through MAP

8 September 2020

Page 1 of 1

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

AFT Pharmaceuticals Limited published this content on 08 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2020 04:29:03 UTC


© Publicnow 2020
All news about AFT PHARMACEUTICALS LIMITED
01/18AFT PHARMACEUTICALS : 24-hour efficacy for Crystawash Extend Hand SanitiserOpens..
PU
2020AFT PHARMACEUTICALS : AFP builds North American momentumOpens in a new Window
PU
2020AFT PHARMACEUTICALS : AFP determination of Anita Baldauf independenceOpens in a ..
PU
2020AFT PHARMACEUTICALS : Financial results for half year ended 30 september 2020
AQ
2020Aft Pharmaceuticals Posts Decline in Profit, Rise in Revenue for Six Months E..
MT
2020AFT PHARMACEUTICALS : FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020Ope..
PU
2020AFT PHARMACEUTICALS : Opening european office, signs new partners for maxigesic ..
AQ
2020Aft Pharmaceuticals Opens Ireland Office
MT
2020AFT PHARMACEUTICALS : AFP opening European office, signs new partners for MXGOpe..
PU
2020AFT PHARMACEUTICALS : Welcomes us fda complete response letter
AQ
More news
Financials
Sales 2021 118 M 85,0 M 85,0 M
Net income 2021 11,7 M 8,40 M 8,40 M
Net Debt 2021 26,2 M 18,9 M 18,9 M
P/E ratio 2021 46,7x
Yield 2021 -
Capitalization 533 M 382 M 385 M
EV / Sales 2021 4,75x
EV / Sales 2022 3,93x
Nbr of Employees 86
Free-Float 28,2%
Chart AFT PHARMACEUTICALS LIMITED
Duration : Period :
AFT Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AFT PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,75 NZD
Last Close Price 5,24 NZD
Spread / Highest target 24,0%
Spread / Average Target 9,73%
Spread / Lowest Target -4,58%
EPS Revisions
Managers and Directors
NameTitle
Hartley Atkinson Chief Executive Officer, MD & Executive Director
David Mark Flacks Chairman
Malcolm Tubby Chief Financial Officer & Secretary
Douglas John Wilson Independent Non-Executive Director
Marree Atkinson Executive Director & Chief of Staff
Sector and Competitors
1st jan.Capitalization (M$)
AFT PHARMACEUTICALS LIMITED-4.90%382
JOHNSON & JOHNSON3.18%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.84%202 881